Results 91 to 100 of about 72,883 (309)

Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy [PDF]

, 2016
We present a follow-up case report of a 33-year-old lady with juvenile onset arthritis who developed halo naevi while on treatment with tocilizumab. This case report describes the development of halo naevi, vitiligo and diffuse alopecia areata associated
Emery, P, Goodfield, M, Nadesalingam, K
core   +1 more source

Janus Kinase Inhibitors in the Treatment of Alopecia Areata

Prague Medical Report, 2023
Alopecia areata is a disease of autoimmune origin which causes non scarring hair loss. The extent of alopecia varies from a small patch to complete scalp and body hair loss, which can have huge psychosocial impact for those affected. Treatment modalities
Athanasios J. Stefanis
doaj   +1 more source

Overview of Alopecia Areata [PDF]

Journal of Investigative Dermatology Symposium Proceedings, 2013
Alopecia areata is a complex genetic, immune-mediated disease that targets anagen hair follicles. The disease affects children and adults and is characterized by round or oval patches of hair loss, loss of all scalp hair (alopecia totalis), body hair (alopecia universalis), or ophiasis pattern hair loss.
openaire   +3 more sources

Lichen Planus Following COVID‐19 Infection and Vaccination. Matched Case–Control Study

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background New‐onset lichen planus (LP) development following COVID‐19 infection/vaccination is reported. Since case series cannot be used to study exposure–outcome associations, we designed this matched case–control study to investigate whether COVID‐19‐related events and de novo LP are associated.
Paolo Giacomo Arduino, Alexey Kubanov, Anna Vlasova, Andrey Martynov, Stefano Petti   +4 more
wiley   +1 more source

Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes

Journal of the European Academy of Dermatology and Venereology, 2021
New treatment options may lead to an increased interest in using reliable and sensitive instruments to assess health‐related quality of life in people with alopecia areata (AA).
P. Chernyshov, L. Tomas-Aragones, A. Finlay, L. Manolache, S. Marron, F. Sampogna, S. Spillekom-van Koulil, N. Pustišek, A. Suru, A. Evers, C. Sălăvăstru, Å. Svensson, D. Abeni, C. Blome, F. Poot, G. Jemec, D. Linder, M. Augustin, A. Bewley, S. Salek, J. Szepietowski   +20 more
semanticscholar   +1 more source

Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients

Dermatology Practical & Conceptual
Introduction: Alopecia areata is a type of non-scarring alopecia, which is thought to be associated with T-cell mediated immune response. Objective: This study aims to compare the levels of serum inflammatory markers before and after treatment in ...
Icim Komurcugil, Nermin Karaosmanoğlu
doaj   +1 more source

Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?

Dermatology and Therapy, 2023
Background Numerous studies have indicated that alopecia areata is associated with a chronic systemic inflammation, which is considered as a risk factor for venous thromboembolism.
Anna Waśkiel-Burnat, Adriana Rakowska, Michał Zaremba, Magdalena Maciejewska, Leszek Blicharz, Michela Starace, Matilde Iorizzo, Bianca Maria Piraccini, Małgorzata Olszewska, Lidia Rudnicka   +9 more
doaj   +1 more source

Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy

Allergy, EarlyView.
Ritlecitinib modulated Type I/II immunity genes (CCL5, CD8A, GZMB, CCL13, CCL18, and IL13RA1), MoA genes (JAK3, ITK, and BTK), and upregulated hair keratins, with stronger effects in AAP than AT/AU. Baseline and longitudinal scalp and serum protein changes correlated with hair regrowth and disease improvement.
Li Xi, Elena Peeva, Yuji Yamaguchi, Zhan Ye, Alexandre Lejeune, Craig Hyde, Emma Guttman‐Yassky   +6 more
wiley   +1 more source

Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata

Experimental Dermatology, 2020
Alopecia areata has basically been understood as a type 1 inflammatory disease. Activated NKG2D+CD8+ cells produce the Th1 cytokine interferon‐γ, which leads to the disruption of immune tolerance of hair follicles and the exposure of self‐antigens.
T. Ito, R. Kageyama, S. Nakazawa, T. Honda   +3 more
semanticscholar   +1 more source

Efficacy and safety of methotrexate in alopecia areata [PDF]

Anais Brasileiros de Dermatologia, 2014
BACKGROUND: Alopecia areata is a chronic disorder of the hair follicles and nails, of unknown etiology, with clear autoimmune components and genetic factors.
Mariana Hammerschmidt, Fabiane Mulinari Brenner   +1 more
doaj   +1 more source